Immobilization in Reverse Shoulder Prosthesis

NCT ID: NCT04645329

Last Updated: 2022-03-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-01-01

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Reverse shoulder prostheses are the treatment of choice in elderly patients with rotator cuff arthropathy. Traditionally these patients have been immobilized for 3 weeks in the immediate postoperative period in order to have good pain control. However, there are no studies that determine the most appropriate period of immobilization. In fact, patients undergoing this type of surgery begin rehabilitation exercises within 24 hours of surgery without experiencing increased pain or requiring specific analgesic treatment. There is a demand in the elderly to limit immobilization time as much as possible, as some live alone and need to be self-sufficient and others have dependents. It would be good to know if it is really necessary to make an immobilization in these patients undergoing this type of surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rotator Cuff Tear Arthropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized prospective study. (computer-generated randomization list and saved in opaque envelopes)
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
outcomes assessor will be blinded to the allocation of the patients

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

group I (no immobilization)

patients will be allowed to freely use their arm without any immobilization after surgery

Group Type EXPERIMENTAL

shoulder immovilization sling

Intervention Type DEVICE

immobilization of the arm after surgery

group II (3-week immobilization)

patients will be kept in an immobilization device for three weeks after surgery

Group Type ACTIVE_COMPARATOR

shoulder immovilization sling

Intervention Type DEVICE

immobilization of the arm after surgery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

shoulder immovilization sling

immobilization of the arm after surgery

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients undergoing primary surgery of inverted prosthesis for rotator cuff arthropathy.
* age between 65-85 a.
* without inflammatory pathologies (rheumatoid arthritis, psoriatic arthritis, ...)
* acceptance to be part of the study.

Exclusion Criteria

* prosthetic surgery prior to the affected limb.
* other indications of reverse prosthesis other than rotator cuff arthropathies (acute fractures, sequelae fractures, tumor surgery, prosthetic revision surgeries).
* no acceptance to participate in the study.
Minimum Eligible Age

65 Years

Maximum Eligible Age

85 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital del Mar

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carlos Torrens

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Carlos Torrens, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Chief Clinic of Parc de Salut Mar

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital del Mar

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Carlos Torrens, MD, PhD

Role: CONTACT

0034933674201

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Carlos Torrens, MD, PhD

Role: primary

0034933674201

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019/8752/I

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Rotator Cuff Pathway
NCT03717753 COMPLETED NA